Awọn itumọ ọrọ sisọ:

Oclacitinib?,> 98%; PF-03394197 (oclacitinib); Oclacitinib PF-03394197; JAKi; trans-N-Methyl-4- (methyl-7H-pyrrolo [2,3-d] pyrimidin-4-ylamino) -cyclohexanemethanesulfonamide ; CyclohexaneMethanesulfonaMide, N-Methyl-4- (Methyl-7H-pyrrolo [2,3-d] pyriMidin-4-ylaMino) -, trans-; N-methyl-1- ((1r,4r) -4- (methyl). (7H-pyrrolo [2,3-d] pyrimidin-4-yl) amino) cyclohexyl) methanesulfonamide; N-Methyl-1- (trans-4- (methyl (7H-pyrrolo [2,3-d]] pyrimidin-4) -yl) amino) cyclohexyl) methanesulfonamide

SILES Canonical:CNS(=O)(=O)CC1CCC(CC1)N(C)C2=NC=NC3=C2C=CN3

Ìwúwo:1.316± 0.06g/cm3 (Asọtẹlẹ)

PKA:11.59± 0.40 (Asọtẹlẹ)